glp·helper
glphelper.com/mounjaro/texas/port-arthur
Dual GIP / GLP-1 receptor agonistFDA-approved May 2022Rx · Subcutaneous injection · Once weekly

Mounjaro® providers &
prescriptions in Port Arthur, TX

Verified Mounjaro providers in Port Arthur, TX. Checked against the NPI registry, sorted by waitlist, not by who pays us.[7]

average Mounjaro weight losstrial-anchored estimate
city providers
24
as of today
median wait
8d
first visit
telehealth
71%
of providers
cash range
$25 to $1,150
monthly
§ 02Provider directory: Texas
25 of 25 shown

Find a Mounjaro provider in Texas.

Every entry is checked against the NPI registry and the Texas medical board. Listings are ordered by current waitlist. The provider who can see you fastest appears first. We do not accept payment for placement.

Filter →
Type
Provider
City
Waitlist
Insurance
Browse by Texas city · /mounjaro/texas/{city}
Abilene
32.45°N
27
Allen
33.11°N
26
Amarillo
35.20°N
32
Arlington
32.74°N
32
Austin
30.27°N
46
Baytown
29.76°N
27
Beaumont
30.08°N
26
Bedford
32.85°N
28
Brownsville
26.00°N
27
Bryan
30.67°N
24
Burleson
32.52°N
25
Carrollton
32.99°N
29
Cedar Hill
32.58°N
23
Cedar Park
30.51°N
28
Channelview
29.79°N
10
Cibolo
29.57°N
6
Cleburne
32.35°N
21
College Station
30.59°N
32
Conroe
30.32°N
24
Coppell
32.96°N
28
Copperas Cove
31.12°N
14
Corpus Christi
27.80°N
34
Dallas
32.78°N
44
Deer Park
29.69°N
12
Del Rio
29.37°N
13
Denton
33.22°N
38
DeSoto
32.60°N
25
Duncanville
32.65°N
25
Edinburg
26.32°N
37
El Paso
31.76°N
37
Euless
32.85°N
30
Farmers Branch
32.93°N
18
Flower Mound
33.04°N
29
Fort Worth
32.75°N
34
Friendswood
29.51°N
28
Frisco
33.16°N
38
Galveston
29.30°N
38
Garland
32.91°N
25
Georgetown
30.67°N
29
Grand Prairie
32.69°N
32
Grapevine
32.93°N
27
Haltom City
32.82°N
6
Harker Heights
31.06°N
24
Harlingen
26.19°N
29
Houston
29.76°N
37
Huntsville
30.70°N
21
Hurst
32.84°N
19
Irving
32.86°N
38
Keller
32.93°N
25
Killeen
31.08°N
25
Kyle
29.99°N
26
La Porte
29.67°N
18
Lancaster
32.60°N
13
Laredo
27.56°N
26
League City
29.49°N
25
Leander
30.57°N
23
Lewisville
33.05°N
27
Little Elm
33.19°N
25
Longview
32.52°N
30
Lubbock
33.58°N
31
Lufkin
31.32°N
27
Mansfield
32.57°N
30
McAllen
26.20°N
37
McKinney
33.20°N
30
Mesquite
32.76°N
27
Midland
32.02°N
27
Midlothian
32.47°N
25
Mission
26.20°N
24
Missouri City
29.56°N
31
Nacogdoches
31.61°N
23
New Braunfels
29.70°N
25
North Richland Hills
32.86°N
25
Odessa
31.88°N
37
Pasadena
29.65°N
26
Pearland
29.56°N
37
Pflugerville
30.45°N
28
Pharr
26.17°N
23
Plano
33.02°N
42
Port Arthur
29.83°N
25
Prosper
33.24°N
29
Richardson
32.97°N
29
Rockwall
32.92°N
24
Rosenberg
29.55°N
19
Round Rock
30.53°N
39
Rowlett
32.92°N
24
San Angelo
31.44°N
33
San Antonio
29.42°N
38
San Juan
26.19°N
12
San Marcos
29.87°N
24
Schertz
29.56°N
20
Sherman
33.63°N
21
Southlake
32.95°N
26
Spring
30.06°N
29
Sugar Land
29.59°N
30
Temple
31.11°N
41
Texarkana
33.45°N
22
Texas City
29.43°N
25
The Colony
33.09°N
22
The Woodlands
30.17°N
23
Tyler
32.32°N
36
Victoria
28.83°N
24
Waco
31.56°N
30
Waxahachie
32.40°N
27
Weatherford
32.75°N
29
Weslaco
26.16°N
32
Wichita Falls
33.91°N
31
Wylie
33.04°N
23
§ 03Getting Mounjaro in Texas
25 providers · 107 metros

How a prescription works in Texas.

You don’t have to leave Texas to start. Because tirzepatide isn't a controlled substance, a Texas-licensed prescriber can evaluate you by telehealth and send the script to a pharmacy near you, or you can see one of the 25 local providers below in person. What you pay depends on your plan, not your zip code.

Telehealth
Available in Texas
Mounjaro (tirzepatide) is a GLP-1, not a controlled substance, so a Texas-licensed clinician can assess you and prescribe over video, with no federal in-person-visit requirement.
Who can prescribe
TX-licensed clinicians
Any physician, nurse practitioner, or PA licensed in Texas can prescribe Mounjaro. The 25 providers below are checked against the NPI registry and the Texas board.
Medicaid (weight loss)
Diabetes only
As of April 2026, Texas Medicaid covers GLP-1s for diabetes but not for weight loss. Employer and private plans can still cover them; that is a plan-design choice, not a state rule.

Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm Texas’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.

§ 04Medication factsheet
cited · last review 2026.05.19

An injectable medication for chronic weight management in adults. Same molecule as Ozempic, higher dose.

Mounjaro is the brand name Eli Lilly uses for tirzepatide approved for type 2 diabetes. It is a once-weekly subcutaneous injection and the first approved dual GIP/GLP-1 receptor agonist. It activates two gut-hormone pathways rather than one. The identical molecule, marketed as Zepbound, is the FDA-approved formulation for chronic weight management.[2][3]

In the SURPASS-2 head-to-head trial, tirzepatide produced greater HbA1c reductions and greater weight loss than semaglutide 1 mg across all doses. Across the SURPASS program, tirzepatide lowered HbA1c by approximately 1.8 to 2.6 percentage points. Mounjaro is approved as an adjunct to diet and exercise for glycemic control in adults with type 2 diabetes.[1]

At a glanceMultiple (per dose)
Generic name
tirzepatide
Drug class
Dual GIP / GLP-1 receptor agonist
Manufacturer
Eli Lilly
FDA approved
May 2022
Approved use
Type 2 diabetes mellitus (adults)
Off-label use
Weight management (Zepbound is the FDA-approved tirzepatide for obesity)
Administration
Subcutaneous injection · Once weekly
Available doses
2.5 mg · 5 mg · 7.5 mg · 10 mg · 12.5 mg · 15 mg
Half-life
≈ 5 days
Pregnancy
Discontinue ≥ 2 months before a planned pregnancy; may reduce oral contraceptive efficacy
§ 05Support around Mounjaro in Port Arthur
5 dietitians

The prescription is one part. Here is the rest, in Port Arthur.

Trials of tirzepatide paired the drug with diet counseling and regular activity. Every name below is a real listing near Port Arthur, TX, ordered as the registry lists them, never by who pays us.

Registered dietitians

A registered dietitian builds the food plan around your prescription. Call to ask about GLP-1 nutrition plans and insurance.

Tanisha Bodden, RDN., LD
RD
Registered dietitian
7365 Crown Meadows Dr
Call 832-754-9004NPI 1831005339
Stephanie Dodson, MS, RD, LD
RD
Registered dietitian
2555 Jimmy Johnson Blvd
Call 409-853-5016NPI 1093213555
Connor O'Shaughnessy, RD, LD
RD
Registered dietitian
2555 Jimmy Johnson Blvd
Call 409-853-5558NPI 1598264616
Rose Quirante, MS RD LD
RD
Registered dietitian
4000 Blackberry Ln
Call 409-722-4067NPI 1144588716
Lavanya Srinivasan, RD
RD
Registered dietitian
3787 Doctors Dr
Call 409-983-2039NPI 1447321559
§ 06Clinical evidence
STEP 1 to 4 + SELECT (N = 17,604)

What the trials actually showed.

We summarize the SURPASS diabetes program, including the SURPASS-2 head-to-head against semaglutide. Figures are means at each trial's primary endpoint.

Across the SURPASS program, tirzepatide reduced HbA1c by approximately 1.8 to 2.6 percentage points and produced substantial weight loss, outperforming insulin and GLP-1 comparators. Mounjaro is approved as an adjunct to diet and exercise for glycemic control in adults with T2D.[4]
STEP / SELECT endpoint table2.4 mg / 68 wk
HbA1c reduction (T2D)
−1.8 to −2.6%
SURPASS program[4]
vs. semaglutide 1 mg
Superior
SURPASS-2, HbA1c + weight[3]
Mean weight change (15 mg, obesity)
−20.9%
SURMOUNT-1, 72 wk (Zepbound)[2]
Effect size varies with baseline characteristics and adherence. Individual response may differ materially.
average Mounjaro weight lossmapped to your starting weight
§ 07Safety & adverse events
from FDA label, sect. 6.1

Most side effects are gastrointestinal and resolve within weeks.

The most common adverse events in STEP trials were nausea (44%), diarrhea (30%), and vomiting (24%), more frequent at the 2.4 mg dose than at Ozempic doses, but typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]

Boxed warning. Boxed warning: risk of thyroid C-cell tumors. Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Effect
Frequency
Severity
Note
Nausea
12 to 24%
mild
Dose-dependent; usually eases after titration
Diarrhea
12 to 19%
mild
More frequent during dose escalation
Vomiting
5 to 13%
mild
Reduced by slower titration
Constipation
6 to 17%
mild
Decreased appetite
5 to 11%
mild
Expected pharmacologic effect
Pancreatitis
<0.3%
serious
Discontinue if acute pancreatitis is suspected
Gallbladder disease
~1 to 2%
serious
Cholelithiasis risk rises with rapid weight loss
Thyroid C-cell tumors
rodent data
boxed warning
Contraindicated with MTC or MEN-2 history
§ 08Cost & coverage, published, not gated
USD · monthly

Most directories hide the price. We don't.

Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.

Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.

Mounjaro cash price (no insurance)
$1,000 to $1,200
per month
Brand-name retail average[6]
Commercial insurance (T2D)
$25 to $250
per month copay
Usually covered for diabetes with prior authorization
Medicare Part D
$0 to $100
per month
T2D covered; weight-loss indication not covered by law[5]
Manufacturer savings card
as low as $25
per month
Commercial insurance only; eligibility limits apply
Updated weekly · last fetch 2026-05-18 04:00 UTCCost methodology →
Find Mounjaro providers in Texas

NPI-verified Mounjaro (tirzepatide) prescribers and clinics, ordered by availability, never by who pays us.

Mounjaro in other states

Find NPI-verified Mounjaro (tirzepatide) doctors, clinics, and pharmacies in the states we cover, ordered by availability, never by who pays us.

Related GLP-1 research
§ 09Frequently asked: Mounjaro in Texas

The questions people ask before they book.

Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.

Mounjaro and Zepbound are both tirzepatide, made by Eli Lilly, but they carry different FDA-approved indications. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. Insurers treat them as separate products, and coverage differs sharply between the two.[1]